Biotechnology

Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate...

VIR-5500 is a Phase I dual-masked T-cell engager (TCE) candidate designed to tar...

Key Genetic Variants That Influence Disease Risk, Human...

Using a massively parallel reporter assay to test more than 220,000 DNA variants...

BIO warns MFN models are illegal, ineffective, and a th...

Proposals to let decisions by other countries control American drug prices are i...

Meet us in Miami for the BIO Investment and Growth Summit

The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth ...

Music Beats Cancer aims to bring everyone to the stage

The Valley of Death is a healthcare crisis, but the nonprofit, Music Beats Cance...

Processing and Interpreting Untargeted Metabolomics Dat...

MassID expands the number of metabolites that can be identified and used for dow...

Omics in Orlando: A Video Report from AGBT, Day One

Reporting from AGBT in Orlando, Julianna LeMieux reviews key announcements inclu...

Samsung Joins CEPI Vaccine Network to Prepare for Next ...

Samsung Biologics has teamed up with the Coalition for Epidemic Preparedness Inn...

Fermenter-Extractor-Separator Mixes Uniformly and is Ge...

Leveraging the Taylor vortex produces an all-in-one fermenter-extractor-separato...

Autonomy and Accountability in Bioprocessing

AI is reshaping bioprocess engineering, but full autonomy remains elusive. Hybri...

Bridging the Translation Gap for Regenerative Tissues

A muscle-tissue engineering company, MUVON Therapeutics, is set to highlight the...

Precise Locations of Oligodendrocytes, Myelin Density M...

Researchers mapped precise locations of millions of mouse brain oligodendrocytes...

New Protein-Like Polymers Target, Degrade “Undruggable”...

HYDRACs work by displaying multiple copies of two components: peptides that reco...

Strategies for Addressing Resistance and Off-Target Tox...

In this GEN webinar, experts from ChemPartner, Philip Clarke, PhD, Hu Liu, PhD, ...

Beam Designs New Approach for Direct Correction of Muta...

Beam’s liver-targeted genetic disease program, BEAM-304, leverages Beam’s propri...

Tamarind Bio Secures $13.6M Series A to Make AI More Ac...

Tamarind’s platform for model coordination and inference enables user-friendly A...